Investigative Ophthalmology & Visual Science

Last updated

History

The journal was established as an official publication of the Association for Research in Ophthalmology (later renamed the Association for Research in Vision and Ophthalmology). The first issue of Investigative Ophthalmology was published in January 1962, with Bernard Becker, MD, as the Executive Editor. The title was changed to Investigative Ophthalmology & Visual Science in 1977. [2]

Abstracts from the ARVO Annual Meeting have been published as an issue of IOVS since 1977. [2]

Also in 1977, IOVS was accepted for inclusion in Index Medicus (and later in MEDLINE) and PubMed.

IOVS was first published online in 1999, with scanned back content being made available online in 2005. The last print issue was published in 2009, and the journal is now published online only. [2]

In January 2016, IOVS ended its subscription program and became open access. [3] All content is freely available to read, and content published 2016-onward is freely available for reuse under either the Creative Commons Attribution-NonCommercial-NoDerivatives license or Creative Commons Attribution license.

Editors

See also

Related Research Articles

<span class="mw-page-title-main">Myopia</span> Problem with distance vision

Myopia, also known as near-sightedness and short-sightedness, is an eye disease where light from distant objects focuses in front of, instead of on, the retina. As a result, distant objects appear blurry while close objects appear normal. Other symptoms may include headaches and eye strain. Severe myopia is associated with an increased risk of macular degeneration, retinal detachment, cataracts, and glaucoma.

Vision science is the scientific study of visual perception. Researchers in vision science can be called vision scientists, especially if their research spans some of the science's many disciplines.

A spasm of accommodation is a condition in which the ciliary muscle of the eye remains in a constant state of contraction. Normal accommodation allows the eye to "accommodate" for near-vision. However, in a state of perpetual contraction, the ciliary muscle cannot relax when viewing distant objects. This causes vision to blur when attempting to view objects from a distance. This may cause pseudomyopia or latent hyperopia.

<span class="mw-page-title-main">PEDF</span> Protein-coding gene in the species Homo sapiens

Pigment epithelium-derived factor (PEDF) also known as serpin F1 (SERPINF1), is a multifunctional secreted protein that has anti-angiogenic, anti-tumorigenic, and neurotrophic functions. Found in vertebrates, this 50 kDa protein is being researched as a therapeutic candidate for treatment of such conditions as choroidal neovascularization, heart disease, and cancer. In humans, pigment epithelium-derived factor is encoded by the SERPINF1 gene.

<span class="mw-page-title-main">Pedram Hamrah</span> German-American ophthalmologist

Pedram Hamrah is a German-American ophthalmologist and immunologist. He obtained his M.D. from the University of Cologne, Germany.

<span class="mw-page-title-main">Intraretinal microvascular abnormalities</span> Medical condition

Intraretinal microvascular abnormalities (IRMA) are abnormalities of the blood vessels that supply the retina of the eye, a sign of diabetic retinopathy. IRMA can be difficult to distinguish from and is likely a precursor to retinal neovascularization. One way to distinguish IRMA from retinal neovascularization is to perform fluorescein angiography. Since IRMA blood vessels are patent, unlike neovascular vessels, they do not leak, and therefore exhibit hyperfluorescence on fluorescein angiography.

The Association for Ocular Pharmacology and Therapeutics (AOPT) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of ocular disease, pharmacology and therapeutics.

<span class="mw-page-title-main">Reza Dana</span> American ophthalmologist and immunologist

Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.

<span class="mw-page-title-main">Filippo Drago (pharmacologist)</span> Italian pharmacologist, neurologist, and psychiatrist

Filippo Drago is an Italian pharmacologist, neurologist and psychiatrist.

<span class="mw-page-title-main">Irvine–Gass syndrome</span> Medical condition

Irvine–Gass syndrome, pseudophakic cystoid macular edema or postcataract CME is one of the most common causes of visual loss after cataract surgery. The syndrome is named in honor of S. Rodman Irvine and J. Donald M. Gass.

<span class="mw-page-title-main">Farhad Hafezi</span> Swiss eye surgeon and researcher (born 1967)

Farhad Hafezi is a prominent Swiss eye surgeon and researcher. Hafezi first gained recognition as a leading retina researcher in 1994, having been the first to discover a gene responsible for light-induced retinal degeneration. However, he changed his research focus to the cornea in 2003, and it is this work, particularly on corneal collagen cross-linking (CXL), which he helped pioneer, and advanced laser refractive surgery that he is internationally known for today. Hafezi's current clinical and laboratory research is focused on gaining a better understanding of the cornea. His research group at the University of Zurich has three main research foci:

Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.

<span class="mw-page-title-main">Emily Chew</span> American ophthalmologist

Emily Ying Chew is an American ophthalmologist and an expert on the human retina with a strong clinical and research interest in diabetic eye disease and age-related eye diseases. She currently works for the National Eye Institute (NEI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she serves as deputy director of the Division of Epidemiology and Clinical Applications (DECA) and the Institute's deputy clinical director. She designs and implements Phase 1, 2 and 3 clinical trials at the NIH Clinical Center. Chew is board certified in ophthalmology.

<span class="mw-page-title-main">Daniel M. Albert</span> American ophthalmologist, ocular cancer researcher and medical historian

Daniel M. Albert is an American ophthalmologist, ocular cancer researcher, medical historian, and collector of rare books and ocular equipment. As of 2018, he is Professor of Ophthalmology at the Casey Eye Institute, Oregon Health & Science University.

Patricia Ann D'Amore is a professor at Harvard Medical School, where she is the Charles L. Schepens Professor of Ophthalmology, and Professor of Pathology.

The Association for Research in Vision and Ophthalmology is an American learned society dedicated to ophthalmology and other vision-related topics. It is based in Rockville, Maryland.

Herbert Edward Kaufman is an American ophthalmologist who discovered idoxuridine, the first clinically useful antiviral agent; co-developed with William Bourne the clinical specular microscope to view the live corneal endothelium, co-developed timolol with Thomas Zimmerman, a new class of medications to treat glaucoma; corneal storage media for eye banks; natamycin, the first commercially available medication to treat fungal infections of the eye; co-developed with Tony Gasset the use of bandage contact lenses; and was involved in the first laser vision photorefractive keratectomy of the eye with Marguarite McDonald.

Alon Harris is an American clinical scientist, professor of ophthalmology and Professor of Artificial Intelligence and Human Health, educator, inventor and researcher in the field of ocular blood flow and its relationship to diseases of the eye. Harris served as the principal or co-principal investigator on more than 60 research grants, published more than 392 peer-reviewed articles, and wrote 23 books and 70 book chapters. As of 2021, he holds two patents. Harris sits on the board of directors and the Scientific Advisory Board of The Glaucoma Foundation and is the Vice Chair of International Research and Academic Affairs, co-director of the Center for Ophthalmic Artificial Intelligence and Human Health at Mount Sinai Hospital, and Director of the Ophthalmic Vascular Diagnostic and Research Program at Icahn School of Medicine at Mount Sinai.

<span class="mw-page-title-main">Alfredo Sadun</span> American ophthalmologist

Alfredo Arrigo Sadun is an American ophthalmologist, academic, author and researcher. He holds the Flora L. Thornton Endowed Chair at Doheny Eye Centers-UCLA and is Vice-Chair of Ophthalmology at UCLA.

Sheila Kay West is an American ophthalmologist who is the El-Maghraby Professor of Preventive Ophthalmology at the Wilmer Eye Institute. She is also the vice-chair for Research.

References

  1. About IOVS, Accessed November 14, 2017.
  2. 1 2 3 Colson, KS. Brief history of Investigative Ophthalmology & Visual Science. In Chader GJ, Frank RN, Kaufman PL, Beebe DC, eds. The Best of Investigative Ophthalmology & Visual Science: The First 50 Years 1962-2012. Rockville, MD: ARVO; 2012:1-5.
  3. ARVO journals open access overview